153 related articles for article (PubMed ID: 15963503)
21. Bradykinin-induced airway microvascular leakage is potentiated by captopril and phosphoramidon.
Lötvall JO; Tokuyama K; Barnes PJ; Chung KF
Eur J Pharmacol; 1991 Aug; 200(2-3):211-7. PubMed ID: 1782987
[TBL] [Abstract][Full Text] [Related]
22. Effects of inhibiting neutral endopeptidase and kininase II on coronary and systemic hemodynamics in rats.
Maxwell AJ; Husseini WK; Piedimonte G; Hoffman JI
Am J Physiol; 1995 Sep; 269(3 Pt 2):H1016-29. PubMed ID: 7573497
[TBL] [Abstract][Full Text] [Related]
23. (99m)Tc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice.
Kaloudi A; Nock BA; Lymperis E; Krenning EP; de Jong M; Maina T
Nucl Med Biol; 2016 Jun; 43(6):347-54. PubMed ID: 27260775
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
Pelorosso FG; Brodsky PT; Zold CL; Rothlin RP
J Pharmacol Exp Ther; 2005 Jun; 313(3):1355-60. PubMed ID: 15764737
[TBL] [Abstract][Full Text] [Related]
25. Degradation of bradykinin in human urine by carboxypeptidase Y-like exopeptidase and neutral endopeptidase and their inhibition by ebelactone B and phosphoramidon.
Saito M; Majima M; Katori M; Sanjou Y; Suyama I; Shiokawa H; Koshiba K; Aoyagi T
Int J Tissue React; 1995; 17(5-6):181-90. PubMed ID: 8835628
[TBL] [Abstract][Full Text] [Related]
26. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ.
Suzuki H; Gao XP; Olopade CO; Rubinstein I
Am J Physiol; 1996 Aug; 271(2 Pt 2):R393-7. PubMed ID: 8770140
[TBL] [Abstract][Full Text] [Related]
27. NEP inhibitors enhance C-type natriuretic peptide-induced relaxation in porcine isolated coronary artery.
Márton Z; Pataricza J; Krassói I; Varró A; Papp JG
Vascul Pharmacol; 2005 Oct; 43(4):207-12. PubMed ID: 16169283
[TBL] [Abstract][Full Text] [Related]
28. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
Johnson AG; Pearce GL; Danoff TM
J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
[TBL] [Abstract][Full Text] [Related]
31. Peptidase inhibitors reverse steroid-induced suppression of neutrophil adhesion in rat tracheal blood vessels.
Katayama M; Nadel JA; Piedimonte G; McDonald DM
Am J Physiol; 1993 Mar; 264(3 Pt 1):L316-22. PubMed ID: 8460720
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
[TBL] [Abstract][Full Text] [Related]
33. Electrically evoked itch in humans.
Ikoma A; Handwerker H; Miyachi Y; Schmelz M
Pain; 2005 Jan; 113(1-2):148-54. PubMed ID: 15621375
[TBL] [Abstract][Full Text] [Related]
34. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis.
Schmelz M; Luz O; Averbeck B; Bickel A
Neurosci Lett; 1997 Jul; 230(2):117-20. PubMed ID: 9259478
[TBL] [Abstract][Full Text] [Related]
35. Neutral endopeptidase modulates substance P-induced vasodilation in vivo.
Gao XP; Rubinstein I
J Appl Physiol (1985); 1995 Feb; 78(2):562-8. PubMed ID: 7538997
[TBL] [Abstract][Full Text] [Related]
36. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
37. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome.
Leis S; Weber M; Schmelz M; Birklein F
Neurosci Lett; 2004 Apr; 359(3):163-6. PubMed ID: 15050689
[TBL] [Abstract][Full Text] [Related]
38. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia.
Weglicki WB; Chmielinska JJ; Tejero-Taldo I; Kramer JH; Spurney CF; Viswalingham K; Lu B; Mak IT
Magnes Res; 2009 Sep; 22(3):167S-173S. PubMed ID: 19780404
[TBL] [Abstract][Full Text] [Related]
39. Viral infection potentiates the increase in airway blood flow produced by substance P.
Yamawaki I; Geppetti P; Bertrand C; Chan B; Massion P; Piedimonte G; Nadel JA
J Appl Physiol (1985); 1995 Aug; 79(2):398-404. PubMed ID: 7592194
[TBL] [Abstract][Full Text] [Related]
40. Effects of KB-2796 on plasma extravasation following antidromic trigeminal stimulation in the rat.
Hashimoto M; Yamamoto Y; Takagi H
Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):79-94. PubMed ID: 9507571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
